Capillary Technologies Allots 1,16,748 Shares Under Employee Stock Option Scheme
Bengaluru based Capillary Technologies India Limited has completed the allotment of equity shares under its Employee Stock Option Scheme 2021 ESOP plan. The Board of Directors' Nomination and Remuneration Committee approved this transaction on July 23, 2026.The Company allotted a total of 1,16,748 equity shares, fully paid up, upon the exercise of vested options granted under the Capillary Employees stock option scheme 2021. The issue details confirm that these new shares are identical in all respects to existing equity shares of the Company and rank pari passu.
Key financial details of the share allotment include:
- Date of Issue: July 23, 2026
- Number of Shares Issued: 1,16,748
- Exercise Price per Share: ₹ 2/-
- Premium per Share: Nil
Following this issuance, the total issued shares of Capillary Technologies India Limited stand at 7,95,88,731. The corresponding total issued share capital after the allotment is reported at Rs.15,91,77,462/-.
The shares allotted under the ESOP plan carry the ISIN number INE0ILV01024 and were designated with distinctive numbers ranging from 79471984 to 79588731.
CAPILLARY Stock Price Movement
As of 12:52 PM, shares of Capillary Technologies India Limited are slipping by 0.27% in live trading, currently resting at ₹478.7. The stock has seen a volume of 4,875 shares traded so far in the market session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.